Cuál es el precio por Midatech Pharma plc (MTPH)

Precio por Midatech Pharma plc (MTPH) es de$0.05309195

Cuál es la capitalización de mercado por Midatech Pharma plc (MTPH)

Capitalización de mercado por Midatech Pharma plc (MTPH) es $164.43

Midatech Pharma plc (MTPH) Dividendos

Midatech Pharma plc operates as a pharmaceutical company specializing in drug delivery technologies. Its core activities revolve around the research and development of therapeutic compounds, with operations spanning the United Kingdom, broader Europe, and global markets. Currently, its pipeline includes several key developments: MTX110, an innovative direct-delivery therapy targeting diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immunosuppressant designed for topical use against psoriasis; MTD211, a sustained-release version of brexpiprazole intended for managing schizophrenia and as an add-on therapy for major depressive disorder; and MTD219, a prolonged-action formulation of tacrolimus aimed at reducing the likelihood of organ transplant rejection. Beyond its specific drug candidates, Midatech Pharma provides advanced drug delivery platforms. These include Q-Sphera, a microtechnology based on polymer microspheres that enables drugs to be released over extended periods; MidaSolve, a nanotechnology employing oligosaccharides to enhance drug solubility, allowing direct and localized administration into tumors; and MidaCore, a gold nanoparticle system engineered to precisely deliver chemotherapeutic or immunotherapeutic agents to disease sites. Established in 2000, the company maintains its headquarters in Cardiff, United Kingdom.

Año	Dividendo (ajustado por splits de acciones)	Cambiar
Not enough data for the provided dates.

Año

Dividendo (ajustado por splits de acciones)

Cambiar

Not enough data for the provided dates.

Año	Dividendo	Cambiar
Not enough data for the provided dates.

Año

Dividendo

Cambiar

Not enough data for the provided dates.

Empresa	Número de pagos de dividendos	País
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Lonza Group AG LONN.SW	0.00%	CH
UCB S.A. UCB.BR	29.00%	BE
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR

Empresa

Número de pagos de dividendos

País